Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

2.799 -0.021 (-0.75%)

Streaming Delayed Price Updated: 3:20 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 28, 2022

Via Benzinga

Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher ↗

November 28, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.

Via Benzinga

Earnings Preview: Anavex Life Sciences ↗

November 25, 2022

Via Benzinga

Recap: Anavex Life Sciences Q1 Earnings ↗

February 09, 2022

Anavex Life Sciences (NASDAQ:AVXL) reported its Q1 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For February 9, 2022 ↗

February 09, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.

Via Benzinga

CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday ↗

November 28, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Earnings Scheduled For November 28, 2022 ↗

November 28, 2022

Companies Reporting Before The Bell • Pinduoduo (NASDAQ:PDD) is projected to report quarterly earnings at $0.65 per share on revenue of $4.31 billion.

Via Benzinga

This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk' ↗

November 15, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."

Via Benzinga

Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients

October 20, 2022

Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...

Via FinancialNewsMedia

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday ↗

July 19, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 14, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022 ↗

June 23, 2022

Upgrades

Via Benzinga

Anavex: Alzheimer's To Parkinson's Dementia ↗

April 15, 2022

Following a huge gain in 2021 (after a big gain in 2020), the shares have given back 27% year-to-date as investors ride out a quiet stretch awaiting trial results.

Via Talk Markets

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL

April 05, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Anavex Life Sciences Corp. (NASDAQ:AVXL) Investor Alert: Investigation over Potential Wrongdoing ↗

March 21, 2022

San Diego, CA -- (SBWIRE) -- 03/21/2022 -- An investigation on behalf of investors in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) was announced over potential breaches of fiduciary duties by...

Via SBWire

Anavex Life Sciences Highlights Biomarker Data From Parkinson's Disease Dementia At International Conference ↗

March 15, 2022

Via Benzinga

NASDAQ:AVXL Shareholder Notice: Investigation over Potential Securities Laws Violations by Anavex Life Sciences Corp. ↗

February 23, 2022

San Diego, CA -- (SBWIRE) -- 02/23/2022 -- Anavex Life Sciences Corp. is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗

February 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

February 04, 2022

Los Angeles - (NewMediaWire) - February 04, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life...

Via NewMediaWire

Investigation Notice: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

February 03, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ANAVEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Anavex Stockholders and Encourages Investors to Contact the Firm

February 02, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors

February 02, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors

February 02, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors

February 02, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

February 02, 2022

From The Schall Law Firm

Via Business Wire

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 02, 2022

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out: Executives buy more than $600 million of 3...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 50 Points; DLH Holdings Shares Drop ↗

February 01, 2022

US stocks traded mixed in the afternoon session on Tuesday after recording sharp gains in the previous session. Wall Street closed the volatile January month with steep losses.

Via Benzinga

52 Biggest Movers From Yesterday ↗

February 02, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix...

Via Benzinga

Anavex Life Sciences Crashes As Last-Minute Testing Edits Cloud Drug's Impact ↗

February 01, 2022

Just two weeks ago, Anavex edited the goals of its study in Rett syndrome.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.